Log in

NASDAQ:MNLOMenlo Therapeutics SEC Filings & 10K Form

$1.06
+0.03 (+2.91 %)
(As of 04/9/2020 07:53 AM ET)
Add
Compare
Today's Range
$1.00
Now: $1.06
$1.14
50-Day Range
$1.03
MA: $3.25
$5.53
52-Week Range
$1.00
Now: $1.06
$7.85
Volume5.06 million shs
Average Volume1.75 million shs
Market Capitalization$25.91 million
P/E RatioN/A
Dividend YieldN/A
Beta1.84

SEC Filings

Menlo Therapeutics (NASDAQ:MNLO) SEC Filings

DateFilerForm TypeView
04/07/2020
4:23 PM
Menlo Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
4:22 PM
Menlo Therapeutics (Issuer)
Stuart Iain (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
4:22 PM
Hirsch Stanley (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
4:22 PM
Harsch Mutya (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
4:21 PM
Domzalski David (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
4:21 PM
Bruno Anthony D (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
4:19 PM
Basta Steven L (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2020
8:00 AM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2020
3:47 PM
Harsch Mutya (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2020
4:01 PM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2020
3:31 PM
Menlo Therapeutics (Issuer)
Saik Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
3:30 PM
Menlo Therapeutics (Issuer)
Saik Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/23/2020
3:45 PM
Menlo Therapeutics (Issuer)
Sandoval Elisabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
3:44 PM
Bruno Anthony D (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
3:44 PM
Bright Rex (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
3:44 PM
Basta Steven L (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
3:43 PM
BARBARI SHARON SURREY (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
6:11 AM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2020
4:57 PM
Menlo Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
4:57 PM
Menlo Therapeutics (Issuer)
Stuart Iain (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
4:57 PM
Hirsch Stanley (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
4:56 PM
Harsch Mutya (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
4:56 PM
Hadar Ilan (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
4:56 PM
Domzalski David (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
4:55 PM
Bruno Anthony D (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
4:55 PM
Bright Rex (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
4:55 PM
Basta Steven L (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
4:54 PM
BARBARI SHARON SURREY (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
4:53 PM
Menlo Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/11/2020
4:53 PM
Menlo Therapeutics (Issuer)
Stuart Iain (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/11/2020
4:52 PM
Hirsch Stanley (Reporting)
Menlo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/11/2020
4:52 PM
Harsch Mutya (Reporting)
Menlo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/11/2020
4:52 PM
Hadar Ilan (Reporting)
Menlo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/11/2020
4:51 PM
Domzalski David (Reporting)
Menlo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/11/2020
4:51 PM
Bruno Anthony D (Reporting)
Menlo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/11/2020
4:50 PM
Bright Rex (Reporting)
Menlo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/11/2020
4:49 PM
BARBARI SHARON SURREY (Reporting)
Menlo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/09/2020
4:24 PM
Menlo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/04/2020
1:56 PM
FIRST MANHATTAN CO (Filed by)
Menlo Therapeutics (Subject)
Form SC 13G/A
01/28/2020
3:04 PM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
3:03 PM
Foamix Pharmaceuticals Ltd. (Subject)
Menlo Therapeutics (Filed by)
Form 425
01/16/2020
3:16 PM
Foamix Pharmaceuticals Ltd. (Subject)
Menlo Therapeutics (Filed by)
Form 425
01/16/2020
3:15 PM
Foamix Pharmaceuticals Ltd. (Subject)
Menlo Therapeutics (Filed by)
Form 425
01/07/2020
11:15 PM
Menlo Therapeutics (Filer)
Form EFFECT
01/07/2020
3:48 PM
Menlo Therapeutics (Filer)
Form 424B3
01/06/2020
3:47 PM
Menlo Therapeutics (Filer)
Form S-4/A
12/20/2019
7:01 AM
Foamix Pharmaceuticals Ltd. (Subject)
Menlo Therapeutics (Filed by)
Form 425
12/16/2019
4:14 PM
BALL KRISTINE M (Reporting)
Menlo Therapeutics (Issuer)
Form 4/A
12/16/2019
4:13 PM
Kwon Paul (Reporting)
Menlo Therapeutics (Issuer)
Form 4/A
12/16/2019
4:11 PM
Basta Steven L (Reporting)
Menlo Therapeutics (Issuer)
Form 4/A
12/13/2019
8:59 PM
Kwon Paul (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
8:58 PM
Krasnow Ronald A. (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
8:56 PM
BALL KRISTINE M (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
8:54 PM
Basta Steven L (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:24 PM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2019
4:22 PM
Foamix Pharmaceuticals Ltd. (Subject)
Menlo Therapeutics (Filed by)
Form 425
12/04/2019
4:19 PM
Menlo Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
11/21/2019
3:11 PM
Foamix Pharmaceuticals Ltd. (Subject)
Menlo Therapeutics (Filed by)
Form 425
11/12/2019
7:41 AM
Foamix Pharmaceuticals Ltd. (Subject)
Menlo Therapeutics (Filed by)
Form 425
11/12/2019
7:41 AM
Foamix Pharmaceuticals Ltd. (Subject)
Menlo Therapeutics (Filed by)
Form 425
11/12/2019
7:19 AM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
7:19 AM
Foamix Pharmaceuticals Ltd. (Subject)
Menlo Therapeutics (Filed by)
Form 425
11/12/2019
5:06 AM
Foamix Pharmaceuticals Ltd. (Filed by)
Menlo Therapeutics (Subject)
Form 425
10/31/2019
3:54 PM
Menlo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2019
3:34 PM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2019
4:28 PM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
8:39 PM
Ebel Ted (Reporting)
Menlo Therapeutics (Issuer)
Form 4/A
08/08/2019
8:24 PM
Menlo Therapeutics (Issuer)
Royston Aaron (Reporting)
Form 4/A
08/08/2019
8:18 PM
BERNS PAUL L (Reporting)
Menlo Therapeutics (Issuer)
Form 4/A
08/08/2019
8:17 PM
Menlo Therapeutics (Issuer)
Whitcup Scott M (Reporting)
Form 4/A
08/08/2019
8:17 PM
MCGIRR DAVID W J (Reporting)
Menlo Therapeutics (Issuer)
Form 4/A
08/07/2019
6:30 PM
Basta Steven L (Reporting)
Menlo Therapeutics (Issuer)
Form 4/A
08/07/2019
6:29 PM
Kwon Paul (Reporting)
Menlo Therapeutics (Issuer)
Form 4/A
08/07/2019
6:27 PM
BALL KRISTINE M (Reporting)
Menlo Therapeutics (Issuer)
Form 4/A
08/01/2019
3:25 PM
Menlo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
3:17 PM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2019
5:37 PM
Krasnow Ronald A. (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2019
5:35 PM
Basta Steven L (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2019
5:35 PM
BALL KRISTINE M (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2019
5:33 PM
Kwon Paul (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:18 PM
Menlo Therapeutics (Issuer)
Royston Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:18 PM
BERNS PAUL L (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:17 PM
Krasnow Ronald A. (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:17 PM
Menlo Therapeutics (Issuer)
Whitcup Scott M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:15 PM
Ebel Ted (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:15 PM
Krasnow Ronald A. (Reporting)
Menlo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2019
3:15 PM
MCGIRR DAVID W J (Reporting)
Menlo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:15 PM
Menlo Therapeutics (Issuer)
Sandoval Elisabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:08 PM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
3:10 PM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
3:10 PM
Menlo Therapeutics (Filer)
Form DEFA14A
05/02/2019
3:24 PM
Menlo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
3:15 PM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2019
7:08 AM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2019
3:38 PM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2019
3:10 PM
Menlo Therapeutics (Issuer)
Sandoval Elisabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
3:05 PM
Menlo Therapeutics (Issuer)
Sandoval Elisabeth (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2019
7:50 AM
Menlo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
3:07 PM
GREAT POINT PARTNERS LLC (Filed by)
Menlo Therapeutics (Subject)
Form SC 13G/A
02/14/2019
1:09 PM
Menlo Therapeutics (Subject)
Merck & Co., Inc. (Filed by)
Form SC 13G/A
This page was last updated on 4/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel